The proposed sale is minimal and likely part of routine tax or estate planning. No material signal for the stock. Monitor for any larger insider sales or changes in officer holdings.
Price Chart
Executive Summary
Sarah Gheuens, an officer of Agios Pharmaceuticals, filed a Form 144 on October 22, 2026, indicating intent to sell 500 shares of common stock with an estimated aggregate market value of $18,760. The shares were acquired via stock option exercise. This is a very small sale relative to her prior holdings and the company's market cap, and the filing is routine.
Key Facts
- Insider: Sarah Gheuens (Officer)
- Shares proposed for sale: 500 shares of common stock
- Estimated aggregate market value: $18,760
- Acquisition method: Stock option exercise from issuer
- Filing date: October 22, 2026
- Prior sales: 1,489 shares on October 21, 2026 ($55,881) and 30,000 shares on August 4, 2026 ($914,283)
Financial Impact
Proposed sale of $18,760 — trivial relative to insider's prior sales and company market cap
Risk Factors
- Insider selling pattern could escalate if additional large sales are filed
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010371 |
| Document: 0001950047-26-010371-index.html | 0001950047-26-010371 |
| Document: 0001950047-26-010371.txt | 0001950047-26-010371 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 144 | $36.85 | awaiting T+60 | — | $36.85 (−0.00%) |
Oct 22, 2026 4d ago | 144 | $37.00 | awaiting T+60 | — | $36.85 (−0.41%) |
Aug 6, 2026 11w ago | Institutional Cluster | $31.95 | awaiting T+60 | — | $36.85 (+15.34%) |
Jul 30, 2026 12w ago | 8-K | $32.75 $37.00 | ▲ +12.98% | ▲ +10.51% | $36.85 (+12.52%) |
Jul 30, 2026 12w ago | Press Release | $32.75 $37.00 | ▲ +12.98% | ▲ +10.51% | $36.85 (+12.52%) |
Jul 7, 2026 15w ago | Press Release | $44.01 $33.25 | ▼ −24.45% | ▼ −26.44% | $36.85 (−16.27%) |
Jun 29, 2026 17w ago | Press Release | $38.04 $34.97 | ▼ −8.07% | ▼ −12.46% | $36.85 (−3.13%) |
Jun 18, 2026 18w ago | 8-K | $35.10 $32.81 | ▼ −6.52% | ▼ −8.27% | $36.85 (+4.99%) |
Jun 13, 2026 19w ago | Press Release | $31.82 $34.63 | ▲ +8.83% | ▲ +7.83% | $36.85 (+15.81%) |
Jun 1, 2026 21w ago | Press Release | $28.00 $33.90 | ▲ +21.07% | ▲ +19.84% | $36.85 (+31.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers